PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HCM vs. BRK-B
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HCM and BRK-B is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

HCM vs. BRK-B - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-6.67%
5.59%
HCM
BRK-B

Key characteristics

Sharpe Ratio

HCM:

0.21

BRK-B:

1.18

Sortino Ratio

HCM:

0.74

BRK-B:

1.75

Omega Ratio

HCM:

1.08

BRK-B:

1.22

Calmar Ratio

HCM:

0.17

BRK-B:

2.10

Martin Ratio

HCM:

0.59

BRK-B:

4.94

Ulcer Index

HCM:

19.85%

BRK-B:

3.56%

Daily Std Dev

HCM:

56.58%

BRK-B:

14.94%

Max Drawdown

HCM:

-82.18%

BRK-B:

-53.86%

Current Drawdown

HCM:

-62.48%

BRK-B:

-1.04%

Fundamentals

Market Cap

HCM:

$2.75B

BRK-B:

$1.03T

EPS

HCM:

-$0.25

BRK-B:

$49.45

PEG Ratio

HCM:

0.00

BRK-B:

10.06

Total Revenue (TTM)

HCM:

$152.84M

BRK-B:

$276.52B

Gross Profit (TTM)

HCM:

$62.77M

BRK-B:

$48.42B

EBITDA (TTM)

HCM:

-$10.63M

BRK-B:

$98.94B

Returns By Period

In the year-to-date period, HCM achieves a 11.80% return, which is significantly higher than BRK-B's 5.62% return.


HCM

YTD

11.80%

1M

13.61%

6M

-6.66%

1Y

2.87%

5Y*

-9.28%

10Y*

N/A

BRK-B

YTD

5.62%

1M

3.96%

6M

5.59%

1Y

15.31%

5Y*

15.90%

10Y*

12.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HCM vs. BRK-B — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HCM
The Risk-Adjusted Performance Rank of HCM is 5353
Overall Rank
The Sharpe Ratio Rank of HCM is 5555
Sharpe Ratio Rank
The Sortino Ratio Rank of HCM is 5252
Sortino Ratio Rank
The Omega Ratio Rank of HCM is 4949
Omega Ratio Rank
The Calmar Ratio Rank of HCM is 5454
Calmar Ratio Rank
The Martin Ratio Rank of HCM is 5454
Martin Ratio Rank

BRK-B
The Risk-Adjusted Performance Rank of BRK-B is 8080
Overall Rank
The Sharpe Ratio Rank of BRK-B is 8181
Sharpe Ratio Rank
The Sortino Ratio Rank of BRK-B is 7676
Sortino Ratio Rank
The Omega Ratio Rank of BRK-B is 7373
Omega Ratio Rank
The Calmar Ratio Rank of BRK-B is 9191
Calmar Ratio Rank
The Martin Ratio Rank of BRK-B is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HCM vs. BRK-B - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HUTCHMED (China) Limited (HCM) and Berkshire Hathaway Inc. (BRK-B). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HCM, currently valued at 0.21, compared to the broader market-2.000.002.000.211.18
The chart of Sortino ratio for HCM, currently valued at 0.74, compared to the broader market-4.00-2.000.002.004.006.000.741.75
The chart of Omega ratio for HCM, currently valued at 1.08, compared to the broader market0.501.001.502.001.081.22
The chart of Calmar ratio for HCM, currently valued at 0.17, compared to the broader market0.002.004.006.000.172.10
The chart of Martin ratio for HCM, currently valued at 0.59, compared to the broader market-10.000.0010.0020.0030.000.594.94
HCM
BRK-B

The current HCM Sharpe Ratio is 0.21, which is lower than the BRK-B Sharpe Ratio of 1.18. The chart below compares the historical Sharpe Ratios of HCM and BRK-B, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00SeptemberOctoberNovemberDecember2025February
0.21
1.18
HCM
BRK-B

Dividends

HCM vs. BRK-B - Dividend Comparison

Neither HCM nor BRK-B has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HCM vs. BRK-B - Drawdown Comparison

The maximum HCM drawdown since its inception was -82.18%, which is greater than BRK-B's maximum drawdown of -53.86%. Use the drawdown chart below to compare losses from any high point for HCM and BRK-B. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-62.48%
-1.04%
HCM
BRK-B

Volatility

HCM vs. BRK-B - Volatility Comparison

HUTCHMED (China) Limited (HCM) has a higher volatility of 14.00% compared to Berkshire Hathaway Inc. (BRK-B) at 4.27%. This indicates that HCM's price experiences larger fluctuations and is considered to be riskier than BRK-B based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
14.00%
4.27%
HCM
BRK-B

Financials

HCM vs. BRK-B - Financials Comparison

This section allows you to compare key financial metrics between HUTCHMED (China) Limited and Berkshire Hathaway Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab